Injections of -gal glycolipids (Figs. 1, 2) was followed by analysis of the induction of MAA specific T cell response. This was determined by ELISPOT studies with immunodominant MAA peptides of B16 melanoma including: TRP2180?88, gp10025?3 and human gp10025?3 [4]. T cell response evaluated by IFN secretion in ELISPOT with TRP2180?88 (SVYDFFVWL) peptide was higher in five of the six mice with B16 t